Magda N. Nasr - Search Results

Year	Number of Results
2002	3
2003	3
2004	2
2015	1
2021	0

1

Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.

Bayomi SM, El-Kashef HA, El-Ashmawy MB, Nasr MN, El-Sherbeny MA, Abdel-Aziz NI, El-Sayed MA, Suddek GM, El-Messery SM, Ghaly MA. Bayomi SM, et al. Eur J Med Chem. 2015 Aug 28;101:584-94. doi: 10.1016/j.ejmech.2015.07.014. Epub 2015 Jul 14. Eur J Med Chem. 2015. PMID: 26197162

2

Novel 3,3a,4,5,6,7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents.

Nasr MN, Said SA. Nasr MN, et al. Arch Pharm (Weinheim). 2003 Dec;336(12):551-9. doi: 10.1002/ardp.200300796. Arch Pharm (Weinheim). 2003. PMID: 14677148

3

Novel analogues of sydnone: synthesis, characterization and antibacterial evaluation.

Moustafa MA, Gineinah MM, Nasr MN, Bayoumi WA. Moustafa MA, et al. Among authors: nasr mn. Arch Pharm (Weinheim). 2004 Aug;337(8):427-33. doi: 10.1002/ardp.200300847. Arch Pharm (Weinheim). 2004. PMID: 15293261

4

Synthesis and antiinflammatory screening of some quinazoline and quinazolyl-4-oxoquinazoline derivatives.

Gineinah MM, El-Sherbeny MA, Nasr MN, Maarouf AR. Gineinah MM, et al. Among authors: nasr mn. Arch Pharm (Weinheim). 2002;335(11-12):556-62. doi: 10.1002/ardp.200290009. Arch Pharm (Weinheim). 2002. PMID: 12596220

5

Synthesis and biological evaluation of some quinazoline derivatives as antitumor and antiviral agents.

el-Sherbeny MA, Gineinah MM, Nasr MN, el-Shafeih FS. el-Sherbeny MA, et al. Among authors: nasr mn. Arzneimittelforschung. 2003;53(3):206-13. doi: 10.1055/s-0031-1297096. Arzneimittelforschung. 2003. PMID: 12705177

6

Pyrido[2, 3-d]pyrimidines and pyrimido[5',4':5, 6]pyrido[2, 3-d]pyrimidines as new antiviral agents: synthesis and biological activity.

Nasr MN, Gineinah MM. Nasr MN, et al. Arch Pharm (Weinheim). 2002 Jun;335(6):289-95. doi: 10.1002/1521-4184(200208)335:6<289::AID-ARDP289>3.0.CO;2-Z. Arch Pharm (Weinheim). 2002. PMID: 12210772

7

Synthesis and in vitro antibacterial evaluation of novel imidazo[2',1':5,1]-1,2,4-triazolo[4,3-c]-quinazoline derivatives of 5-thioxo-1, 2, 4-triazole, 4-oxothiazolidine, and their open-chain counterparts.

Nasr MN, Gineinah MM, El-Bendary ER. Nasr MN, et al. Arch Pharm (Weinheim). 2003 Dec;336(12):560-6. doi: 10.1002/ardp.200300809. Arch Pharm (Weinheim). 2003. PMID: 14677149

8

Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives.

Nasr MN. Nasr MN. Arch Pharm (Weinheim). 2002 Aug;335(8):389-94. doi: 10.1002/1521-4184(200211)335:8<389::AID-ARDP389>3.0.CO;2-X. Arch Pharm (Weinheim). 2002. PMID: 12397623

9

Synthesis and biological testing of novel analogues of sydnone as potential antibacterial agents.

Moustafa MA, Nasr MN, Gineinah MM, Bayoumi WA. Moustafa MA, et al. Among authors: nasr mn. Arch Pharm (Weinheim). 2004 Mar;337(3):164-70. doi: 10.1002/ardp.200300814. Arch Pharm (Weinheim). 2004. PMID: 15038062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results